Sign in
4

Changes in Ownership

Coherus Oncology, Inc. Filed Acc 0001567619-20-001040

Chief Scientific Officer gave up 3,477 shares (to pay taxes)

  • Chief Scientific Officer acquired 40,150 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Vexler Vladimir · Chief Scientific Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2020-01-10 Grant or award : show line 1 in the form +8,900 28,412 D
2020-01-10 Shares withheld for taxes : show line 2 in the form −3,477 $17.73 $61,647 24,935 D
2020-01-10 Grant or award : show line 3 in the form +31,250 56,185 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2020-01-10 Grant or award : show line 4 in the form Stock Option (Right to Buy) +62,500 62,500 D
Loading xslF345X03/doc1.xml…